Advanced Search

 

Study ID Status Title Patient Level Data
H73-020-V Completed The Effects of Probenecid and Cimetidine on the Pharmacokinetics of Valaciclovir and its Metabolite Acyclovir in Healthy Male Volunteers
HAZ30001 Completed A prospective, randomised, open-label, blinded-endpoint, parallel group study comparing telmisartan plus hydrochlorothiazide with losartan plus hydrochlorothiazide in subjects with essential hypertension.
HAZ30002 Completed A prospective, randomised, open-label, parallel group study to investigate the effects of 12 months treatment with telmisartan plus hydrochlorothiazide or ramipril plus hydrochlorothiazide on left ventricular mass index in subjects with left ventricular hypertrophy and essential hypertension
HGC10007 Completed A randomised, placebo controlled, parallel group pilot study in patients with allergic rhinitis due to house dust mite to determine i) the effectiveness of 7 days treatment with fluticasone propionate 200 m/day, upon nasal clinical response and nasal biopsy after intranasal allergen challenge…
HGC10008 Completed A randomised, double-blind, double-dummy, placebo-controlled, three-way crossover study in patients with allergic rhinitis due to house dust mite to compare the effect versus placebo of 7 days treatment with a new chemical entity (NCE) administered…
HGS1021-C1063 Completed A randomized, single-blind, placebo-controlled study to evaluate the safety and tolerability of raxibacumab (human monoclonal antibody to B. anthracis protective antigen) in healthy subjects Study Listed on ClinicalStudyDataRequest.com
HGS1021-C1069 Completed An Open-Label Study to Evaluate the Immunogenicity and Safety of Raxibacumab (Human Monoclonal Antibody to B. anthracis Protective Antigen) Administered in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
HH3104994 Completed A randomised, double blind, placebo controlled, two way crossover, three phase study to investigate the trial models; Vienna Challenge Chamber, in and out of season and Park study in season and the clinical efficacy of repeat doses of fluticasone propionate in subjects with seasonal allergic rhinitis (SAR).
HH3110161 Completed See Detailed Description Study Listed on ClinicalStudyDataRequest.com
HHI110157 Completed See Detailed Description Study Listed on ClinicalStudyDataRequest.com
HM2006/00198/00 Completed A randomised, double-blind, parallel-group, placebo controlled study to investigate the anxiolytic effects of repeat dosing of 20mg and 40mg paroxetine.
HPR20001 Terminated Phase IIB, Randomized, Multicenter, Parallel Group, Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effect of Four Blinded Dosing Regimens of GW640385X/ritonavir Compared to Open-label Current PI therapy in HIV-1 infected, Protease Inhibitor Experienced Adults for 2 weeks with Long-term Assessment (>48 weeks) of Safety, Pharmacokinetic and Antiviral Activity of Selected 385/RTV Dosing Regimen(s) vs. a Ritonavir-boosted, Protease Inhibitor Containing Regimen
HPV-Meta-analysis-201110 Completed Integrated Safety Summary of GSK Biologicals’ HPV-16/18 L1 VLP AS04 vaccine (Cervarix®)
HS2100275 Completed An International, Randomized, Double-Blind, Placebo-Controlled, Multicenter, 6-Month Study of the Efficacy and Safety of Valtrex 1g QD vs. Placebo for the Suppression of HSV-2 Genital Herpes in Newly Diagnosed Immunocompetent Patients Study Listed on ClinicalStudyDataRequest.com
HS2101951 Completed Clinical Evaluation of Valaciclovir Hydrochloride: 256U87 in Patients with Chickenpox - Open Uncontrolled Study.
HS210909 Completed Report of a Study to Evaluate the Bioequivalence of Single Doses of an Investigational Formulation of Valaciclovir Compared to the Standard Valaciclovir Tablet in Healthy Volunteers
HS210911 Completed A Randomised, Open-Label, Cross-Over, Single Dose Study to Evaluate the Pharmacokinetic Interaction Between Aciclovir 800mg and Mycophenolate Mofetil 1000mg and Between Valaciclovir 2000mg and Mycophenolate Mofetil 1000mg in Healthy Volunteers
HS210914 Completed An open-label, single-dose, multicenter, pharmacokinetic, safety and tolerability study of valaciclovir oral suspension in infants and children. Study Listed on ClinicalStudyDataRequest.com
HS210915 Completed An open-label, multiple-dose, multicenter, pharmacokinetic, safety and tolerability study of valaciclovir oral suspension in infants and children with HSV infection Study Listed on ClinicalStudyDataRequest.com
HS210916 Completed An open-label, multiple-dose, multicenter, pharmacokinetic, safety and tolerability study of valaciclovir oral suspension in infants and children with VZV infection Study Listed on ClinicalStudyDataRequest.com
HS230017 Completed An open-label, randomized, crossover study to determine subject treatment preference and efficacy of once daily valacyclovir 500 mg suppression therapy versus valacyclovir 500 mg twice daily treatment for recurrent genital HSV infections.
HS230018 Completed An International, Randomized, Double-Blind, Placebo-Controlled Study of Valaciclovir for the Suppression of Recurrent Ano-Genital HSV Infections in HIV-Infected Subjects Study Listed on ClinicalStudyDataRequest.com
HS230027 Completed A Multicenter, Double-Blind, Placebo-Controlled Evaluation of Valaciclovir for the Reduction of the Length of Cold Sore Episodes Study Listed on ClinicalStudyDataRequest.com
HS230028 Completed A Multicenter, Double-Blind, Placebo-Controlled Evaluation of Valaciclovir for the Prevention/Blockage of the Progression of Cold Sore Lesion Development Study Listed on ClinicalStudyDataRequest.com
HS240016 Completed CSF Penetration of Acyclovir and its Metabolites After High Dose Valacyclovir Administration

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.